Healthcare Trending Market Reports

  Endovascular Aneurysm Repair Devices Market Research Report: By Indication (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, and Others), by Site (Infrarenal and Pararenal), by Anatomy, and by Products (Percutaneous EVAR and Others)- Forecast Till 2027 Endovascular Aneurysm Repair Devices Market Scenario Endovascular aneurysm repair devices market is likely to grow significantly over the forecast period. It is estimated that the endovascular aneurysm repair devices market is expected to record a CAGR ~ 6.4 % during the forecast period of 2018 to 2023. The weakening and bulging of the aorta is called aortic aneurysm. The bulging can cause a leak that spills blood into the body. It can direct the blood flow away from the organs and tissues, causing severe complications, such as kidney damage, heart attacks, stroke, and even death. Thus, endovascular repair can be done by placing a stent-graft in an aneurysm through a small hole in the blood vessels in the groin area. also read @  h

  Market Scenario: The Global Chronic Granulomatous Disease Market is expected to grow at a steady pace over the forecast period. The chronic granulomatous disease is a rare inherited disorder which is passed on from parents to their children. People with this disease have weak immune systems which leave their body vulnerable to chronic inflammation and frequent bacterial and fungal infections. The symptoms of this disease develop in the infancy or in the early childhood. The symptoms of this disease vary from person to person. Some common signs and symptoms may include frequent bacterial and fungal infections, swollen lymph nodes, persistent diarrhea, abscesses involving liver, lungs, spleen, bones, or skin. Factors such as the growing prevalence of rare diseases, increasing expenditure on healthcare sector in the developed economies, and increasing research and development activities are anticipated to drive the growth of the market. However, expensive diagnostic tests and lack of aw

      The worldwide Tenecteplase Drug Market is perceived to have a good run during the forecast period (2018-2023), says Market Research Future (MRFR). MRFR expects the market to grow at a lucrative rate during the conjectured time frame. Market Boosters and Key Challenges Tenecteplase drug refers to a recombinant enzyme that acts as a blood thinning agent. Also known as a clot buster, tenecteplase drug helps dissolve blood clots or clumps, allowing the blood to flow normally. These drugs are generally used for treating patients facing heart-related issues. Some of the leading factors influencing the market growth include the increasing number of hypertension patients, rising number of deep vein thrombosis cases, early aging, and sedentary lifestyles that lead to blood clotting. The American Heart Association reported in 2017 that every 40 seconds, an individual in the United States (U.S) gets a heart attack. The American College of Cardiology reported in 2018 that the death rate due

  Rheumatic Fever Market Analysis Global Rheumatic Fever Market Research Report: By Diagnosis (Physical Exam, Blood Test, Electrocardiogram, Other), by Treatment (Pharmacotherapy), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others), by End-User– Forecast Till 2027 Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @  https://www.marketresearchfuture.com/sample_request/6310 Rheumatic fever is caused by an incorrectly treated strep throat, which can cause complications such as rheumatic fever. Rheumatic fever is an autoimmune disease and can cause lasting damage to the heart and heart valves. The growing prevalence of strep throat is a major driver for the global rheumatic fever market over the forecast period. Increasing prevalence of rheumatic heart disease is also a major driver for the global rheumatic fever market over the forecast period. Rheumatic fever is mostly seen in the age group of 5 to 15 years, however, adults may

  Global Singleplex Immunoassay Market Research Report: By Products and Services (Consumables, Others), by Type (Protein-Based Assays, Nucleic Acid Based Assays, Others), Technology (Flow Cytometry, Others), Application, End-User - Global Forecast Till 2027 On the other hand, stringent FDA regulations and emergence of other immunoassay technologies many hamper the growth of the market during the forecast period 2018-2023. read more @  https://www.medgadget.com/2019/01/singleplex-immunoassay-market-ready-to-booming-healthcare-sector-with-8-4-cagr-during-2017-2023-market-research-future.html Market Scenario The global singleplex immunoassay market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global singleplex immunoassay market is expected to register a CAGR ~ 8.4 % during the forecast period of 2018–2023. Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multipl

  Heart pump devices market was valued at USD 1,000 million in 2017 and is expected to grow at a CAGR of 12.5% during the forecast period, 2018–2023. The global heart pump devices market is majorly driven by the high prevalence of cardiovascular diseases, growing more elderly population leading to rising patient population affected with heart disorders, and growing penetration by market players. For instance, according to the American Heart Association, in 2014, one in every three deaths in the U.S. was due to cardiovascular disorders. Similarly, cardiovascular disorders had claimed over 801,000 lives in 2014 in the U.S. Additionally, the availability of heart pumps acts as an alternative during a shortage of heart donors, as heart pumps help in pumping the blood to the rest of the body. However, factors such as high cost of heart pump devices are likely to hamper the growth of the market. Request Free Sample Report:   https://www.marketresearchfuture.com/sample_request/6034 Heart Pump

  Biobanking Market Research Report: By Product & Services (Equipment, Consumables, and Services), Sample Type (Blood Products), Storage Type (Manual Storage), Application (Regenerative Medicine) and End-User (Hospitals, Others) – Global Forecast till 2027 Global Biobanking Market Set to Grow at a CAGR of 7.6% during 2018 – 2023 Get Exclusive Sample Copy @  https://www.marketresearchfuture.com/sample_request/5967   Market Synopsis The biobanking market was valued at USD 950 million in 2017 and is expected to register a CAGR of 7.6% during the forecast period. The global biobanking market is majorly driven by the increasing applications in life sciences, increasing technical advanced devices, increasing demand for research activities in genomics for studying various diseases, and growing penetration by market players. Additionally, factors such as increasing government and private funding to support the regenerative medicine research are likely to boost the market growth during the

  Facial Paralysis Market Information: By Type (Bell’s Palsy, Ramsay Hunt Syndrome), by Diagnosis (Electromyography, Computerized Tomography), by Treatment (Medications, Physical Therapy), End-User (Hospitals, Specialty Centers) – Global Forecast Till 2027 Market Highlights Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion. Global Facial Paralysis market is expected to grow at a CAGR of 6.5% during the forecast period. get sample @  https://www.marketresearchfuture.com/sample_request/5942   Factors that are likely to hamper the growth of the market are product failures and recalls. Global Facial Paralysis market is expected to grow at a CAGR of 6.5% during the forecast period. Segments                                                                                                           

  Tachycardia Market Information: By type (Atrial Fibrillation, Atrial Flutter), by Treatment (Vagal Maneuvers, Medications), by Diagnosis (Imaging Tests, Electrocardiogram), and End-User (Hospitals & Clinics, Specialty Centers) – Global Forecast Till 2027 Market Highlights Tachycardia is a common type of heart disorder, which results in a faster heartbeat. Tachycardia can be caused due to various conditions such as heart diseases including coronary artery disease, drinking large amounts of alcohol, and medical conditions such as thyroid disease and certain lung diseases. GET FREE SAMPLE @  https://www.marketresearchfuture.com/sample_request/5883 Global Tachycardia Market is expected to grow at a CAGR of 6.5% during the forecast period. Regional Analysis The Americas dominates the global tachycardia market owing to the increasing aging population, which eventually leads to increase in patient population. Additionally, increasing obesity rates along with increasing cardiovascular di

 Blepharitis Market Research Report: Type (Anterior Blepharitis, Posterior Blepharitis, Mixed Blepharitis) Treatment (Eye Cleansers, Antibiotic Therapy) Diagnosis (Physical Examination) End User (Hospitals, Specialty Centers) – Global forecast till 2027 Global Blepharitis Market is expected to grow at a CAGR of 6.5% during the forecast period. To Get Sample Report visit  https://www.marketresearchfuture.com/sample_request/5766 Key Players for Global Blepharitis Market Some of the leading players in the global blepharitis market are Scope Ophthalmics Ltd, NovaBay Pharmaceuticals, Inc., Merck & Co., InSite Vision Incorporated, Galderma S.A., Perrigo Laboratories, Thea Pharmaceuticals Limited, and Novartis AG. March 14 th , 2019, Bruder announced in a press release about the launch of its two dry eye products, named Eyeleve Contact Lens Compress and Bruder Hygienic Eyelid Solution. The solutions are said to be safe and secure for daily and long-term use for patients suffering with con

 Market Research Future has recently added another market study to its extensive research portfolio, titled “Black Lung Disease Market Research Report — Forecast to 2027”. The report offers intelligent insights and uses thorough examination of market factors to gauge market size and development. Key players in global black lung disease market The key players for the  Global Black Lung Disease Market  are Boehringer Ingelheim International GmbH (Germany), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), AstraZeneca (U.K), Koninklijke Philips N.V. (The Netherlands), GENERAL ELECTRIC (U.S.), Siemens AG (Germany), TOSHIBA CORPORATION (Japan), Medtronic (U.S.), and others. Request Free Sample at  https://www.marketresearchfuture.com/sample_request/5711 Black Lung Disease Market Scenario Black lung disease or coal workers’ pneumoconiosis is caused by long exposure to coal dust and is commonly diagnosed in many of the coal miners. The medical

  Market Scenario: Ebstein’s anomaly is a rare congenital disease that occurs due to improper development of the tricuspid valve in the first eight weeks of fetal growth. This disorder occurs when the tricuspid valve that divides the two chambers of the right side of the heart does not form correctly. The global Ebstein’s Anomaly market is driven by the increasing number of congenital heart diseases and growing population; growing market players has increased the scope of Ebstein’s Anomaly market. Technological advancements, owing to which new and advanced products are being launched in the market, is another factor propelling the growth of this market. Ebstein’s anomaly may be due to many factors, including genetics and the environment. Children born in a family with a history of heart defects may be more likely to have Ebstein’s anomaly. The mother’s exposure to certain medications, such as lithium, can lead to Ebstein’s anomaly in the child. Get Free Sample Copy @  https://www.marke

 Healthcare IT Market Research Report: By Products and Services (Healthcare Provider Solutions, Healthcare Payer Solutions) Component (Services, Software) End-User (Healthcare Providers, Healthcare Payers, Research Centers)- Forecast Till 2027 Healthcare IT Market Overview Healthcare IT Market size is expected to have a CAGR of approximately 12% during 2020 to 2027 and it is expected to reach USD 1,92,638.5MN by 2027. Healthcare Information Technology (IT) is a vast field that applies IT for creating, designing, using, and maintaining the data systems in the field of healthcare. The market for healthcare IT is anticipated to grow at an immense rate due to the collective demand for improved healthcare facilities along with technological advancements in this field, globally. Also Read @  https://www.medgadget.com/2020/08/coronavirus-business-impact-healthcare-it-market-size-2020-technology-developments-industry-growth-rate-carg-status-top-key-players-size-estimation-upcoming-trends.html

 Oral Care Market Information By Product (Toothbrush, Toothpaste, Mouthwash, Others) By Distribution Channel (Store-based, Non-store based)- Forecast 2027 GET FREE SAMPLE @  https://www.marketresearchfuture.com/sample_request/6526 Oral Care Market Snapshot: The oral care market size is expected to register a CAGR of 5.8% during the assessment period of 2020 to 2027, to reach USD 60.9 Billion by 2027. Market Research Future (MRFR)’s analysis projects that the oral care market size is set to witness healthy growth in the foreseeable future. The growth trajectory of the market is guided by increasing awareness about dental care coupled with rising prevalence of dental disorders. Report Overview: MRFR’s report offers a comprehensive analysis of the oral care market share including current market status, key developments, and industry trends. A revenue analysis is available based on store-based and non-store based distribution channels. The discussion also covers different types of products

  Animal Health Market: Information by Animal Type (Farm animal, Companion animal), Product (Pharmaceuticals, Vaccines, Feed Additives), Route of Administration (Oral, Parenteral), Distribution Channel (Retail, E-Commerce) — Global Forecast till 2028 The Global Animal Health Market to account for USD 99 Billion by 2028 registering a CAGR of 8.5% during the forecast period (2021–2028). READ MORE @  https://www.medgadget.com/2021/08/animal-health-market-report-trends-research-shared-by-companies-monitoring-of-animal-disease-economy-contribution-and-forecast-by-2028.html Market Segmentation  The segmental analysis of the global animal health market is done by product, animal type, distribution channel, and route of administration. The product-based segments of the global animal health market are vaccines, pharmaceuticals, and feed additives. The pharmaceuticals segment has been sub-segmented into anti-infectives, analgesics, parasiticides, anti-inflammatory, and others. The vaccines segme